C. Sampaio

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).

H. Gómez, C. Barrios, G. Werutsky, 2016, Clinical breast cancer.

Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care

M. Gnant, P. Ruff, C. Hendricks, 2021, JCO global oncology.

Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)

H. Gómez, A. Guerrero-Zotano, A. Lluch, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?

C. Barrios, R. Caponero, J. Vinholes, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System

C. Barrios, M. Caleffi, T. Reinert, 2016, Journal of global oncology.

Abstract P4-12-26: A phase II randomized study of lapatinib in combination with capecitabine, vinorelbine or gemcitabine as first or second line-therapy in patients with HER2 positive metastatic breast cancer progressing after taxane (LACOG 0801)

H. Gómez, C. Barrios, G. Werutsky, 2013 .

Quality-of-care implications of improving physician communication through a Web-based tool (Teamwork).

T. Mulvey, C. Sampaio, V. Bertoni, 2012, Journal of Clinical Oncology.